» Authors » Jie-Ping Yu

Jie-Ping Yu

Explore the profile of Jie-Ping Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 817
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding F, Yu H, Li Y, Cui N, Dai J, Yu J
J Med Virol . 2015 May; 87(12):2067-73. PMID: 26010146
The coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg (anti-HBs) in patients with hepatitis B virus (HBV) infection has been discovered and explained for several decades, but...
2.
Liu J, Fu X, Zhou W, Yu H, Yu J, Luo H
World J Gastroenterol . 2011 Jan; 17(2):181-90. PMID: 21245990
Aim: To examine the effects of combined treatment of oxaliplatin and phosphatidylinositol 3'-kinase inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) for gastric cancer. Methods: Cell viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptotic cells...
3.
Fu X, Yu J, Luo H, Yu H
Zhonghua Nei Ke Za Zhi . 2010 Jul; 49(5):422-5. PMID: 20646419
Objective: To study the expression of PTEN and its significance in doxorubicin-treated gastric cancer cells. Methods: (1) Gastric cancer BGC-823 cells were treated with doxorubicin. Cell proliferation and apoptosis were...
4.
Ai Y, Yu H, Yu J, Yang Y, Li H, Hu X, et al.
Zhonghua Zhong Liu Za Zhi . 2008 Dec; 30(7):494-7. PMID: 19062713
Objective: To explore whether PI3K/Akt/mdm2 signalling pathway affect the sensitivity of gastric cancer cell line SGC7901 cells to doxorubicin. Methods: Gastric cancer cell line SGC7901 cells were exposed to doxorubicin...
5.
Huang Y, Yu J, Wang G, Chen Z, Wang Q, Xiao L
World J Gastroenterol . 2007 Nov; 13(45):6060-5. PMID: 18023100
Aim: To investigate changes in vasoactive intestinal polypeptide (VIP) and corticotrophin releasing factor (CRF) in the plasma and duodenum of chronic stress-induced depressed rats and the effects of fluoxetine hydrochloride...
6.
Yu H, Ai Y, Yu L, Zhou X, Liu J, Li J, et al.
Int J Cancer . 2007 Oct; 122(2):433-43. PMID: 17935137
The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3-kinase (PI3K)/Akt pathway in the development of chemoresistance...
7.
Cao J, Yu J, Liu C, Chen X, Liu S, Luo H, et al.
Zhonghua Zhong Liu Za Zhi . 2007 Sep; 29(5):346-50. PMID: 17892129
Objective: To explore the effects of human FRNK gene on E-cadherin/beta-catenin complex in colon cancer cell line Colo320WT cells stimulated with extrinsic gastrinl7. Methods: AdEasy system was used to construct...
8.
Cao J, Yu J, Zhou L, Song W, Luo H, Yu H
Zhonghua Yi Xue Za Zhi . 2007 Sep; 87(24):1704-8. PMID: 17825155
Objective: To explore the molecular mechanism of increasing the invasion of colon cancer cells by gastrin 17. Methods: The plasmid pCR 3.1/GR expressing the gastrin receptor cholecystokinin-2 receptor (CCK-2R) was...
9.
Shi L, Zhang B, Yu H, Yu J, Xi J
J Perinat Med . 2007 Jul; 35(5):443-6. PMID: 17624936
Aim: Neonatal necrotizing enterocolitis (NEC) is the most common gastrointestinal disease of premature infants. The role of cytokines and growth factors in the pathophysiology of NEC is not yet clearly...
10.
Ming M, Yu J, Zhou Y, Cao J, Song W, Yu H, et al.
Zhonghua Zhong Liu Za Zhi . 2007 Jun; 29(1):4-8. PMID: 17575684
Objective: To study the effect of gastrin on the mRNA and protein expression of urokinase-type plasminogen activator (u-PA) in human colon cancer cells and detect the role of p38 MAPK...